DoJ (Department of Justice) probe brings orthopaedics pricing in US into spotlight
This article was originally published in Clinica
Executive Summary
The news that Zimmer, Stryker, DePuy Orthopaedics, Biomet and Smith & Nephew have all received subpoenas from the US Department of Justice appears to signal an intent on the part of the authorities to crack down on the close relationships between orthopaedics companies and the surgeons that use their implants.
You may also be interested in...
The Dog That Didn’t Bark: ODAC Gives Nod To Three Products Despite Negative FDA Reviews
Oncologic Drugs Advisory Committee was swayed by views of its disease area experts in favorably reporting out Geron’s imetelstat for myelodysplastic syndromes and supplemental applications for the CAR-T products Carvykti and Abecma in earlier lines of multiple myeloma.
Demi Moore’s Wonderbelly Antacid Investment Lands Supporting Role In Her Promotional Posts
Wonderbelly Antacids “free from” ad claims work but failing to disclose Demi Moore is an investor in her promotions doesn’t, NAD says. Dakota Nutrition fails again on NAD’s test of its testing for elderberry in its supplements.
UroGen Approaches A Big Expansion In Bladder Cancer
The oncology company is preparing for the launch of UGN-102 for bladder cancer. CEO Liz Barrett talked to Scrip about the company’s next growth phase.